A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults

Neuropsychologia

Volumn 56, Issue 1, 2014, Pages 1-8

  Green, Adam E ^a   Gray, Jeremy R ^b   DeYoung, Colin G ^c   Mhyre, Timothy R ^d   Padilla, Robert ^d   DiBattista, Amanda M ^a,d   William Rebeck, G ^d  

^a GEORGETOWN UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APOE; CLU; Executive attention; FMRI; Medial temporal lobe

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; ALLELE; ALZHEIMER DISEASE; APOE EPSILON 4 GENE; ARTICLE; ATTENTION; BRAIN ELECTROPHYSIOLOGY; CLU C GENE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TASK; MILD COGNITIVE IMPAIRMENT; PATHOGENESIS; RISK ASSESSMENT; TEMPORAL LOBE; YOUNG ADULT;

APOE; CLU; EXECUTIVE ATTENTION; FMRI; MEDIAL TEMPORAL LOBE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; ATTENTION; CLUSTERIN; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; OXYGEN; TEMPORAL LOBE; YOUNG ADULT;

EID: 84892490222     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2013.12.020     Document Type: Article

References (72)

1. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
2. Ashburner J., Friston K.J. Voxel-based morphometry-The methods. NeuroImage 2000, 11:805-821.
3. Banich M.T., Burgess G.C., Depue B.E., Ruzic L., Bidwell L.C., Hitt-Laustsen S., Du Y.P., Willcutt E.G. The neural basis of sustained and transient attentional control in young adults with ADHD. Neuropsychologia 2009, 47:3095-3104.
4. Bateman R.J., Xiong C., Benzinger T.L., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M., Holtzman D.M., Santacruz A., Buckles V., Oliver A., Moulder K., Aisen P.S., Ghetti B., Klunk W.E., McDade E., Martins R.N., Masters C.L., Mayeux R., Ringman J.M., Rossor M.N., Schofield P.R., Sperling R.A., Salloway S., Morris J.C. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine 2012, 367:795-804.
5. Beckmann C.F., Smith S.M. Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Transactions on Medical Imaging 2004, 23:137-152.
6. Belleville S., Chertkow H., Gauthier S. Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychology 2007, 21:458-469.
7. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nature Genetics 2007, 39:17-23.
8. Bookheimer S., Burggren A. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annual Review of Clinical Psychology 2009, 5:343-362.
9. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine 2000, 343:450-456.
10. Borghesani P.R., Johnson L.C., Shelton A.L., Peskind E.R., Aylward E.H., Schellenberg G.D., Cherrier M.M. Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers. Neurobiology of Aging 2008, 29:981-991.
11. Braak H., Thal D.R., Ghebremedhin E., Del Tredici K. Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. Journal of Neuropathology & Experimental Neurology 2011, 70:960-969.
12. Braskie M.N., Jahanshad N., Stein J.L., Barysheva M., McMahon K.L., de Zubicaray G.I., Martin N.G., Wright M.J., Ringman J.M., Toga A.W., Thompson P.M. Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. Journal of Neuroscience 2011, 31:6764-6770.
13. Bunce D., Anstey K.J., Burns R., Christensen H., Easteal S. Does possession of apolipoprotein E varepsilon4 benefit cognitive function in healthy young adults?. Neuropsychologia 2011, 49:1693-1697.
14. Bush G., Shin L.M. The multi-source interference task: An fMRI task that reliably activates the cingulo-frontal-parietal cognitive/attention network. Nature Protocols 2006, 1:308-313.
15. Carrasquillo M.M., Belbin O., Hunter T.A., Ma L., Bisceglio G.D., Zou F., Crook J.E., Pankratz V.S., Dickson D.W., Graff-Radford N.R., Petersen R.C., Morgan K., Younkin S.G. Replication of CLU, CR1, and PICALM associations with alzheimer disease. Archives of Neurology 2010, 67:961-964.
16. Casey B.J., Thomas K.M., Davidson M.C., Kunz K., Franzen P.L. Dissociating striatal and hippocampal function developmentally with a stimulus-response compatibility task. Journal of Neuroscience 2002, 22:8647-8652.
17. Damoiseaux J.S., Seeley W.W., Zhou J., Shirer W.R., Coppola G., Karydas A., Rosen H.J., Miller B.L., Kramer J.H., Greicius M.D. Gender modulates the APOE epsilon4 effect in healthy older adults: Convergent evidence from functional brain connectivity and spinal fluid tau levels. Journal of Neuroscience 2012, 32:8254-8262.
18. DeMattos R.B., Cirrito J.R., Parsadanian M., May P.C., O'Dell M.A., Taylor J.W., Harmony J.A., Aronow B.J., Bales K.R., Paul S.M., Holtzman D.M. ApoE and clusterin cooperatively suppress Abeta levels and deposition: Evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 2004, 41:193-202.
19. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.A., Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimer's & Dementia 2010, 6:303-311.
20. Dumanis S.B., DiBattista A.M., Miessau M., Moussa C.E., Rebeck G.W. APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals. Journal of Neurochemistry 2013, 124:4-14.
21. Dumanis S.B., Tesoriero J.A., Babus L.W., Nguyen M.T., Trotter J.H., Ladu M.J., Weeber E.J., Turner R.S., Xu B., Rebeck G.W., Hoe H.S. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. Journal of Neuroscience 2009, 29:15317-15322.
22. Elliott D.A., Weickert C.S., Garner B. Apolipoproteins in the brain: Implications for neurological and psychiatric disorders. Clinical Lipidology 2010, 51:555-573.
23. Epstein R., Harris A., Stanley D., Kanwisher N. The parahippocampal place area: Recognition, navigation, or encoding?. Neuron 1999, 23:115-125.
24. Erk S., Meyer-Lindenberg A., Opitz von Boberfeld C., Esslinger C., Schnell K., Kirsch P., Mattheisen M., Muhleisen T.W., Cichon S., Witt S.H., Rietschel M., Nothen M.M., Walter H. Hippocampal function in healthy carriers of the CLU Alzheimer's disease risk variant. Journal of Neuroscience 2011, 31:18180-18184.
25. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Journal of the American Medical Association 1997, 278:1349-1356.
26. Fei M., Jianhua W. Apolipoprotein epsilon4-Allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: A meta-analysis of prospective studies. Journal of Molecular Neuroscience 2012.
27. Filbey F.M., Slack K.J., Sunderland T.P., Cohen R.M. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 2006, 17:1585-1590.
28. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., Matthews P.M., Beckmann C.F., Mackay C.E. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:7209-7214.
29. Ghebremedhin E., Schultz C., Thal D.R., Rub U., Ohm T.G., Braak E., Braak H. Gender and age modify the association between APOE and AD-related neuropathology. Neurology 2001, 56:1696-1701.
30. Goldberg T.E., Weinberger D.R. Genes and the parsing of cognitive processes. Trends in Cognitive Sciences 2004, 8:325-335.
31. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. Journal of Neuroscience 1996, 16:4491-4500.
32. Green A.E., Fugelsang J.A., Kraemer D.J., Dunbar K.N. The micro-category account of analogy. Cognition 2008, 106:1004-1016.
33. Green A.E., Kraemer D.J., Deyoung C.G., Fossella J.A., Gray J.R. A gene-brain-cognition pathway: Prefrontal activity mediates the effect of COMT on cognitive control and IQ. Cerebral Cortex 2012.
34. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4637-4642.
35. Han S.D., Bondi M.W. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 2008, 4:251-254.
36. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., Heun R., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics 2009, 41:1088-1093.
37. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics 2009, 41:1088-1093.
38. Hunter J.M., Cirrito J.R., Restivo J.L., Kinley R.D., Sullivan P.M., Holtzman D.M., Koger D., Delong C., Lin S., Zhao L., Liu F., Bales K., Paul S.M. Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice. Brain Research 2012, 1467:120-132.
39. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
40. Kane M.J., Engle R.W. Working-memory capacity and the control of attention: The contributions of goal neglect, response competition, and task set to Stroop interference. Journal of Experimental Psychology: General 2003, 132:47-70.
41. Kang S.W., Shin Y.J., Shim Y.J., Jeong S.Y., Park I.S., Min B.H. Clusterin interacts with SCLIP (SCG10-like protein) and promotes neurite outgrowth of PC12 cells. Experimental Cell Research 2005, 309:305-315.
42. Kim J., Basak J.M., Holtzman D.M. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009, 63:287-303.
43. Koch S., Donarski N., Goetze K., Kreckel M., Stuerenburg H.J., Buhmann C., Beisiegel U. Characterization of four lipoprotein classes in human cerebrospinal fluid. Journal of Lipid Research 2001, 42:1143-1151.
44. Kounnas M.Z., Loukinova E.B., Stefansson S., Harmony J.A., Brewer B.H., Strickland D.K., Argraves W.S. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. Journal of Biological Chemistry 1995, 270:13070-13075.
45. Laird A.R., Eickhoff S.B., Li K., Robin D.A., Glahn D.C., Fox P.T. Investigating the functional heterogeneity of the default mode network using coordinate-based meta-analytic modeling. Journal of Neuroscience 2009, 29:14496-14505.
46. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fievet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanche H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics 2009, 41:1094-1099.
47. Lancaster T.M., Baird A., Wolf C., Jackson M.C., Johnston S.J., Donev R., Thome J., Linden D.E. Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene. European Neuropsychopharmacology 2011, 21:880-884.
48. Lehmann D.J., Refsum H., Nurk E., Warden D.R., Tell G.S., Vollset S.E., Engedal K., Nygaard H.A., Smith A.D. Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: A marked sex difference. The Hordaland Health Study. Journal of Neurology, Neurosurgery & Psychiatry 2006, 77:902-908.
49. Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nature Reviews Neurology 2013, 9:106-118.
50. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience 2006, 7:818-827.
51. Mondadori C.R., de Quervain D.J., Buchmann A., Mustovic H., Wollmer M.A., Schmidt C.F., Boesiger P., Hock C., Nitsch R.M., Papassotiropoulos A., Henke K. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cerebral Cortex 2007, 17:1934-1947.
52. Myers R.H., Schaefer E.J., Wilson P.W., D'Agostino R., Ordovas J.M., Espino A., Au R., White R.F., Knoefel J.E., Cobb J.L., McNulty K.A., Beiser A., Wolf P.A. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 1996, 46:673-677.
53. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994, 264:850-852.
54. Neufang S., Akhrif A., Riedl V., Forstl H., Kurz A., Zimmer C., Sorg C., Wohlschlager A.M. Predicting effective connectivity from resting-state networks in healthy elderly and patients with prodromal Alzheimer's disease. Human Brain Mapping 2013.
55. Nierenberg J., Pomara N., Hoptman M.J., Sidtis J.J., Ardekani B.A., Lim K.O. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. Neuroreport 2005, 16:1369-1372.
56. Pena-Gomez C., Sole-Padulles C., Clemente I.C., Junque C., Bargallo N., Bosch B., Molinuevo J.L., Valls-Sole J., Pascual-Leone A., Bartres-Faz D. APOE status modulates the changes in network connectivity induced by brain stimulation in non-demented elders. PLoS One 2012, 7:e51833.
57. Preston A.R., Gabrieli J.D. Dissociation between explicit memory and configural memory in the human medial temporal lobe. Cerebral Cortex 2008, 18:2192-2207.
58. Ryan L., Lin C.Y., Ketcham K., Nadel L. The role of medial temporal lobe in retrieving spatial and nonspatial relations from episodic and semantic memory. Hippocampus 2010, 20:11-18.
59. Saunders N.L., Summers M.J. Longitudinal deficits to attention, executive, and working memory in subtypes of mild cognitive impairment. Neuropsychology 2011, 25:237-248.
60. Scarmeas N., Habeck C.G., Hilton J., Anderson K.E., Flynn J., Park A., Stern Y. APOE related alterations in cerebral activation even at college age. Journal of Neurology, Neurosurgery & Psychiatry 2005, 76:1440-1444.
61. Schroeter M.L., Vogt B., Frisch S., Becker G., Barthel H., Mueller K., Villringer A., Sabri O. Executive deficits are related to the inferior frontal junction in early dementia. Brain 2012, 135:201-215.
62. Shehzad Z., DeYoung C.G., Kang Y., Grigorenko E.L., Gray J.R. Interaction of COMT val158met and externalizing behavior: Relation to prefrontal brain activity and behavioral performance. NeuroImage 2012, 60:2158-2168.
63. Silveri M.C., Reali G., Jenner C., Puopolo M. Attention and memory in the preclinical stage of dementia. Journal of Geriatric Psychiatry and Neurology 2007, 20:67-75.
64. Tan H.Y., Callicott J.H., Weinberger D.R. Intermediate phenotypes in schizophrenia genetics redux: Is it a no brainer?. Molecular Psychiatry 2008, 13:233-238.
65. Thambisetty M., An Y., Kinsey A., Koka D., Saleem M., Guntert A., Kraut M., Ferrucci L., Davatzikos C., Lovestone S., Resnick S.M. Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. NeuroImage 2012, 59:212-217.
66. Thambisetty M., Beason-Held L.L., An Y., Kraut M., Nalls M., Hernandez D.G., Singleton A.B., Zonderman A.B., Ferrucci L., Lovestone S., Resnick S.M. Alzheimer risk variant CLU and brain function during aging. Biological Psychiatry 2013, 73:399-405.
67. Trachtenberg A.J., Filippini N., Ebmeier K.P., Smith S.M., Karpe F., Mackay C.E. The effects of APOE on the functional architecture of the resting brain. NeuroImage 2012, 59:565-572.
68. Valla J., Yaari R., Wolf A.B., Kusne Y., Beach T.G., Roher A.E., Corneveaux J.J., Huentelman M.J., Caselli R.J., Reiman E.M. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility gene. Journal of Alzheimer's Disease 2010, 22:307-313.
69. Wang L., Zang Y., He Y., Liang M., Zhang X., Tian L., Wu T., Jiang T., Li K. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. NeuroImage 2006, 31:496-504.
70. Wu Z.C., Yu J.T., Li Y., Tan L. Clusterin in Alzheimer's disease. Advances in Clinical Chemistry 2012, 56:155-173.
71. Wylie S.A., Ridderinkhof K.R., Eckerle M.K., Manning C.A. Inefficient response inhibition in individuals with mild cognitive impairment. Neuropsychologia 2007, 45:1408-1419.
72. Zahs K.R., Ashe K.H. 'Too much good news'-are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?. Trends in Neurosciences 2010, 33:381-389.